PhRMA, Sen. Grassley Debate “Corporate Death Penalty” In False Claims Act

The Pharmaceutical Research & Manufacturers of America should focus on helping its members educate employees about the False Claims Act rather than seek changes to the penalties under the law, Senate Finance Committee Chairman Charles Grassley (R-Iowa) declared in an Aug. 26 letter to the trade association